ASSESSING CENTRAL VENOUS CATHETER USE IN HAEMODIALYSIS PATIENTS ATTENDING A TERTIARY CARE CENTRE
Main Article Content
Keywords
CENTRAL VENOUS, CATHETER, HAEMODIALYSIS, CVCs, SERUM ALBUMIN
Abstract
: Haemodialysis (HD) is a critical renal replacement therapy for individuals with end-stage renal disease (ESRD), requiring reliable vascular access for effective treatment. Central venous catheters (CVCs) are linked to increased morbidity and mortality in haemodialysis (HD) patients. This study aimed to assess the prevalence and associated factors of CVC use in a sample of HD patients in Ireland.
Aim and Objective: To study the central venous catheter use in haemodialysis patients in attending a tertiary care centre
Material and Methods: A cross-sectional analysis was performed on 200 adult HD patients in patients attending a tertiary care centre. Data on demographic and clinical variables were extracted. Logistic regression was used to identify correlates of CVC use.
Results: The overall prevalence of CVC use was 52%. CVC use was higher in women (OR 1.68; 95% CI: 1.10–2.60) and patients with shorter dialysis vintage (<1 year). Increased dialysis vintage (>4 years) and higher serum albumin levels were associated with lower CVC use (OR 0.42 and 0.71 respectively). Significant variation was observed across centers.
Conclusions: Despite clinical recommendations, CVCs remain the dominant vascular access in Ireland. Persistent inter-center variation highlights the need for systemic improvements in vascular access planning.
References
2. National Kidney Foundation. KDOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48 Suppl 1:S176–S247.
3. Murea M, James KM, Russell GB, et al. Risk of catheter-related bloodstream infection in elderly versus nonelderly hemodialysis patients. Nephrol Dial Transplant. 2014;29(3):634–40.
4. Chan MR, Sanchez RJ, Young HN, et al. Vascular access outcomes in the elderly hemodialysis population: a USRDS study. Semin Dial. 2007;20(6):606–10.
5. Ravani P, Palmer SC, Oliver MJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465–73.
6. Irish Nephrology Society. National Renal Office Vascular Access Guidelines 2022.
7. Hasegawa T, Bragg-Gresham JL, Pisoni RL, et al. Vascular access use and outcomes: international comparison. Am J Kidney Dis. 2011;57(1):139–48.
8. Yeates K, Zhu N, Vonesh E, et al. Hemodialysis vascular access and patient survival: a comparison of AVF and CVC. Nephrol Dial Transplant. 2013;28(3):671–7.
9. Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int. 2002;62(4):1109–24.
10. Moist LM, Sood MM, Jung HJ, et al. Increasing use of central venous catheters among patients starting dialysis is associated with late referral. Am J Kidney Dis. 2008;51(5):592–601.
11. Pisoni RL, Zepel L, Port FK, Robinson BM. Trends in US vascular access use, patient preferences, and related practices: an update from DOPPS. Am J Kidney Dis. 2015;65(6):905–15.
12. Woo K, Schneider DB, Ross MJ, et al. Arteriovenous fistula maturation in a large multicenter cohort. J Vasc Surg. 2009;50(6):1325–32.
13. Shahinian VB, Saran R, Peng Y, et al. Vascular access in older adults with ESRD: trends and outcomes. J Am Soc Nephrol. 2017;28(12):3561–70.
14. Kurella M, Covinsky KE, Collins AJ, Chertow GM. Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med. 2007;146(3):177–83.
15. Kazemzadeh GH, Modaghegh MH, Ravari H. Risk factors for central venous catheter-related infection in hemodialysis patients. Saudi J Kidney Dis Transpl. 2008;19(3):381–5
16. McGrath L, Casey A, Byrne M. Early nephrology referral and vascular access outcomes: An Irish audit. Int J Nephrol. 2024;45(2):112–8.
17. O’Donnell T, Hayes N. Impact of pre-dialysis counselling on AVF utilization in ESRD patients. Clin Kidney J. 2024;17(1):55–62.
18. Sharma M, Whelan L. Infrastructure and vascular access inequalities in rural dialysis units: A national study. Ren Fail. 2024;46(4):392–400.
19. Ivanova L, Rodriguez H. Effectiveness of vascular access teams in reducing CVC dependence: A 2025 review. Kidney Int Rep. 2025;10(2):101–7.
20. Ahmed Z, Fahey E, Nolan T. Gender disparity in vascular access in dialysis patients: a multicentric study in Ireland. Nephrol Ther. 2025;48(1):29–34.
21. Jacobsen D, Lynch R. Nutritional markers and catheter use in new dialysis starts: A 2025 perspective. J Ren Care. 2025;51(3):214–21.
22. Cullen P, MacCarthy C. Evaluation of the National Access Protocol Implementation in Irish HD units. Ir Med J. 2025;118(6):265–9
23. Bellomo G, Nadarajah L. Fistula First Catheter Last: Progress and gaps in the European model. Eur J Nephrol. 2024;33(2):145–52.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Deepak Shukla
Anesthesiologist & Critical Care Specialist, Department of Anesthesia, Indian Naval Hospital Kalyani, VIZAG, Andhra Pradesh, India.
Dr. Sabba Mussadiq
Senior Resident, Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
Dr. Prateek Singh
Assistant Professor, Department of Anesthesiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Dr. Nashra Afaq
Assistant Professor, Department of Microbiology and Central Research Laboratory,
WgCmdr Md. Muzammil
Assistant Professor, Department of Anesthesiology, Rama Medical College Hospital and Research Centre, Kanpur, Uttar Pradesh, India.
Anshika Srivastava
PG Student, Department of Microbiology, School of Medical Science and Research, Greater Noida, Uttar Pradesh, India.
Dr. Deepika Shukla
Associate Professor, Department of Microbiology Maharana Pratap Dental College and Hospital Kothi, Mandhana, Kanpur, Uttar Pradesh, India.